National Cancer Institute; Notice of Meeting, 29336 [05-10070]
Download as PDF
29336
Federal Register / Vol. 70, No. 97 / Friday, May 20, 2005 / Notices
Dated: May 11, 2005.
Steven M. Ferguson,
Director, Division of Technology Development
and Transfer, Office of Technology Transfer,
National Institutes of Health.
[FR Doc. 05–10065 Filed 5–19–05; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Cancer Institute Board of
Scientific Advisors.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: National Cancer
Institute Board of Scientific Advisors.
Date: June 27–28, 2005.
Time: June 27, 2005, 8 a.m. to 6 p.m.
Agenda: Director’s Report; Ongoing and
New Business; Reports of Program Review
Group(s); and Budget Presentation; Reports of
Special Initiatives; RFA and RFP Concept
Review; and Scientific Presentations.
Place: National Institutes of Health,
Building 31, C Wing, 6 Floor, Conference Rm.
10, 9000 Rockville Pike, Bethesda, MD
20892.
Time: June 28, 2005, 8:30 a.m. to 1 p.m.
Agenda: Ongoing and New Business;
Reports of Program Review Group(s); and
Budget Presentation; Reports of Special
Initiatives; RFA and RFP Concept Review;
and Scientific Presentations.
Place: National Institutes of Health,
Building 31, C Wing, 6 Floor, Conference Rm.
10, 9000 Rockville Pike, Bethesda, MD
20892.
Contact Person: Paulette S. Gray, PhD,
Executive Secretary, Division of Extramural
Activities, National Cancer Institute, National
Institutes of Health, 6116 Executive
Boulevard, 8th Floor, Rm. 8001, Bethesda,
MD 20892, (301) 496–5147.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
into the building by non-government
employees. Persons without a government
I.D. will need to show a photo I.D. and signin at the security desk upon entering the
building.
VerDate jul<14>2003
20:07 May 19, 2005
Jkt 205001
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/bsa.htm, where
an agenda any any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS.)
Dated: May 12, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–10070 Filed 5–19–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2) notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with theprovisions
set forth in sections 552b(c)(4) and
552b(c)(6), Title 5 U.S.C., as amended.
The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Initial Review Group, Subcommittee
F—Manpower & Training.
Date: June 14–15, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Wyndham City Center Hotel, 1143
New Hampshire Ave., NW., Washington, DC
20037.
Contact Person: Lynn M. Amende, PhD,
Scientific Review Administrator, Resources
and Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, 6116 Executive Blvd., Room 8105,
Bethesda, MD 20892, 301–451–4759,
amendel@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS.)
Dated: May 12, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–10071 Filed 5–19–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the meeting of the
National Cancer Advisory Board.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
A portion of the meeting will be
closed to the public in accordance with
the provisions set forth in sections
552b(c)(4), and 552b(c)(6), as amended.
The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Advisory Board Subcommittee on Planning
and Budget.
Open: June 6, 2005, 6:30 p.m. to 9 p.m.
Agenda: To discuss activities related to the
Subcommittee on Planning and Budget.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, Bethesda, MD 20814.
Contact Person: Ms. Cherie Nichols,
Executive Secretary, National Cancer
Institute, National Institutes of Health, 6116
Executive Boulevard, 2nd Floor, Room 205,
Bethesda, MD 20892–2590, (301) 496–5515.
Name of Committee: National Cancer
Advisory Board.
Open: June 7, 2005, 8:30 a.m. to 4:30 p.m.
Agenda: Program reports and
presentations; Business of the Board.
Place: National Cancer Institute, 9000
Rockville Pike, Building 31, C Wing, 6th
Floor, Conference Room 10, Bethesda, MD
20892.
Contact Person: Dr. Paulette S. Gray,
Executive Secretary, National Cancer
E:\FR\FM\20MYN1.SGM
20MYN1
Agencies
[Federal Register Volume 70, Number 97 (Friday, May 20, 2005)]
[Notices]
[Page 29336]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-10070]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of
the National Cancer Institute Board of Scientific Advisors.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: National Cancer Institute Board of Scientific
Advisors.
Date: June 27-28, 2005.
Time: June 27, 2005, 8 a.m. to 6 p.m.
Agenda: Director's Report; Ongoing and New Business; Reports of
Program Review Group(s); and Budget Presentation; Reports of Special
Initiatives; RFA and RFP Concept Review; and Scientific
Presentations.
Place: National Institutes of Health, Building 31, C Wing, 6
Floor, Conference Rm. 10, 9000 Rockville Pike, Bethesda, MD 20892.
Time: June 28, 2005, 8:30 a.m. to 1 p.m.
Agenda: Ongoing and New Business; Reports of Program Review
Group(s); and Budget Presentation; Reports of Special Initiatives;
RFA and RFP Concept Review; and Scientific Presentations.
Place: National Institutes of Health, Building 31, C Wing, 6
Floor, Conference Rm. 10, 9000 Rockville Pike, Bethesda, MD 20892.
Contact Person: Paulette S. Gray, PhD, Executive Secretary,
Division of Extramural Activities, National Cancer Institute,
National Institutes of Health, 6116 Executive Boulevard, 8th Floor,
Rm. 8001, Bethesda, MD 20892, (301) 496-5147.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance into the building by non-government
employees. Persons without a government I.D. will need to show a
photo I.D. and sign-in at the security desk upon entering the
building.
Information is also available on the Institute's/Center's home
page: https://deainfo.nci.nih.gov/advisory/bsa.htm, where an agenda
any any additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS.)
Dated: May 12, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-10070 Filed 5-19-05; 8:45 am]
BILLING CODE 4140-01-M